摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-溴噌啉-4-醇 | 876-88-0

中文名称
6-溴噌啉-4-醇
中文别名
——
英文名称
6-bromocinnolin-4-ol
英文别名
6-bromo-1H-cinnolin-4-one
6-溴噌啉-4-醇化学式
CAS
876-88-0
化学式
C8H5BrN2O
mdl
——
分子量
225.044
InChiKey
VWMHMZLZLNLBPB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    276-277 °C
  • 沸点:
    405.4±48.0 °C(Predicted)
  • 密度:
    1.805±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    41.5
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933990090
  • 危险性防范说明:
    P261,P302+P352,P305+P351+P338
  • 危险性描述:
    H302,H315,H319

SDS

SDS:c286bea3ab46b0a0c6378ff73209b861
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 6-Bromocinnolin-4-ol
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 6-Bromocinnolin-4-ol
CAS number: 876-88-0

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H5BrN2O
Molecular weight: 225.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • PROTOZOAN PARASITE GROWTH INHIBITORS
    申请人:Northeastern University
    公开号:US20150259331A1
    公开(公告)日:2015-09-17
    Compounds and methods for inhibiting growth of a protozoan parasite. Methods of treating a protozoan parasite infection in a subject by administering a therapeutically effective amount of a compound as disclosed herein. The compounds and methods can be used to inhibit growth of protozoan parasites such as Trypanosoma brucei, Trypanosoma cruzi, Leishmania spp., and Plasmodium spp.
    用于抑制原生动物寄生虫生长的化合物和方法。通过向主体施用如本文所述的治疗有效量的化合物来治疗原生动物寄生虫感染的方法。这些化合物和方法可用于抑制如非洲锥虫、克鲁兹锥虫、利什曼原虫属和疟原虫属等原生动物寄生虫的生长。
  • Kinase inhibitors
    申请人:——
    公开号:US20030187026A1
    公开(公告)日:2003-10-02
    Compounds having the formula 1 are useful for inhibiting protein kinases. Also disclosed are compositions which inhibit protein kinases and methods of inhibiting protein kinases in a patient.
    具有以下化学式的化合物对抑制蛋白激酶很有用。还公开了抑制蛋白激酶的组合物以及在患者中抑制蛋白激酶的方法。
  • SOMATOSTATIN MODULATORS AND USES THEREOF
    申请人:Crinetics Pharmaceuticals, Inc.
    公开号:US20180016252A1
    公开(公告)日:2018-01-18
    Described herein are compounds that are somatostatin modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    本文描述了一些肽类调节剂化合物,制备这类化合物的方法,包含这类化合物的药物组合物和药物,以及利用这类化合物治疗需要调节生长抑素活性的疾病、症状或疾病的方法。
  • Discovery of Pyridopyrimidinones as Potent and Orally Active Dual Inhibitors of PI3K/mTOR
    作者:Tao Yu、Ning Li、Chengde Wu、Amy Guan、Yi Li、Zhengang Peng、Miao He、Jie Li、Zhen Gong、Lei Huang、Bo Gao、Dongling Hao、Jikui Sun、Yan Pan、Liang Shen、Chichung Chan、Xiulian Lu、Hongyu Yuan、Yongguo Li、Jian Li、Shuhui Chen
    DOI:10.1021/acsmedchemlett.8b00002
    日期:2018.3.8
    identification and lead optimization of a series of pyridopyrimidinone derivatives are described as a novel class of efficacious dual PI3K/mTOR inhibitors, resulting in the discovery of 31. Compound 31 exhibited high enzyme activity against PI3K and mTOR, potent suppression of Akt and p70s6k phosphorylation in cell assays, and good pharmacokinetic profile. Furthermore, compound 31 demonstrated in vivo
    一系列嘧啶嘧啶酮衍生物的鉴定和前导优化被描述为一类新型的有效PI3K / mTOR双重抑制剂,导致31的发现。化合物31在细胞分析中显示出对PI3K和mTOR的高酶活性,对Akt和p70s6k磷酸化的有效抑制作用,以及良好的药代动力学特征。此外,化合物31在PC-3M肿瘤异种移植模型中显示出体内功效。
  • 噌啉化合物PI3K激酶抑制剂及其制备方法与在制药中的应用
    申请人:复旦大学
    公开号:CN112876456A
    公开(公告)日:2021-06-01
    本发明提供式I所示的噌啉化合物PI3K激酶抑制剂,其中R1,R2,R3,均具有本发明说明书中所限定的含义。本发明还提供式I或其盐的药物组合物和它们的制备方法,以及它们用于PI3K激酶过表达而引发的炎症、免疫疾病、心血管疾病、癌症及与PI3K激酶相关的其它疾病的治疗用途。
查看更多